Intravitreal Injection Anesthesia - Comparison of Different Topical Agents
Status:
Completed
Trial end date:
2009-11-01
Target enrollment:
Participant gender:
Summary
Patients with neovascular age-related macular degeneration (AMD) scheduled to receive
intravitreal (IVT) Ranibizumab injection will be randomized to receive one of three topical
anesthetics: (1) tetracaine drop (gtt) + lidocaine pledget to the injection site for 10
seconds (2) tetracaine gtt alone and (3) cocaine gtt alone. A questionnaire will be conducted
immediately after and 15 minutes after the injection, to assess for pain.